Prenetics to Participate in the 38th Annual ROTH Conference

Prenetics Global Limited (PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA.

Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throughout the conference. Management will also participate in a fireside chat at 8:30 a.m. PT and a Consumer Influencer panel discussion at 12:00 p.m. PT on Monday, March 23rd — both available via webcast at the links above and on the Company's investor relations website.

To schedule a one-on-one meeting with Prenetics' management, please contact Investor Relations at PRE@mzgroup.us or your ROTH representative.

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company's flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 30 countries worldwide.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature's most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8's flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.

Investor Relations Contact:

investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PRE
The Conversation (0)
Altona (LSE: REE)

Final Assay Results Confirm High-Grade, Near-Surface Fluorspar and Gallium Mineralisation at Monte Muambe

Altona (LSE: REE), a resource exploration and development company focused on critical raw materials in Africa, is pleased to announce the receipt of all outstanding assay results from its 2025 drilling campaign at Monte Muambe.HighlightsAll assays received: Final results from the 2025 drilling... Keep Reading...
Kinvestor Mining & Energy 2026 Virtual Investor Conference Agenda Announced for March 26, 2026

Kinvestor Mining & Energy 2026 Virtual Investor Conference Agenda Announced for March 26, 2026

Kin Communications Inc. ("Kin"), Canada's Leading Investor Relations Agency, is pleased to announce the agenda for the Kinvestor Mining & Energy Virtual Investor Conference taking place on Thursday, March 26, 2026. The event welcomes individual and institutional investors, financial advisors,... Keep Reading...
Kinvestor Mining & Energy 2026 Virtual Investor Conference Agenda Announced for March 26, 2026

Kinvestor Mining & Energy 2026 Virtual Investor Conference Agenda Announced for March 26, 2026

Kin Communications Inc. ("Kin"), Canada's Leading Investor Relations Agency, is pleased to announce the agenda for the Kinvestor Mining & Energy Virtual Investor Conference taking place on Thursday, March 26, 2026. The event welcomes individual and institutional investors, financial advisors,... Keep Reading...
Laurion 2026 Strategic Update For Ishkoday: Proposed Dual-Drill Program, Stockpile Gold Recovery Initiative, And Phased Path To Mineral Resource Estimate

Laurion 2026 Strategic Update For Ishkoday: Proposed Dual-Drill Program, Stockpile Gold Recovery Initiative, And Phased Path To Mineral Resource Estimate

Toronto, Ontario — March 24, 2026 TheNewswire — Laurion Mineral Exploration Inc. (TSX-V: LME | OTCQB: LMEFF | FSE: 5YD) ("LAURION" or the "Company") is pleased to announce its 2026 strategic work program at the Ishkōday Gold Project ("Ishkōday" or the "Property"), located 220 kilometres... Keep Reading...
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical TrialsConsistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue SystemsInMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the... Keep Reading...

Charles Schwab's Money Talk Personal Finance Column Expands Bench of Expert Voices

Three new Certified Financial Planners ® join the column's roster of experts creating real-life financial education insight Charles Schwab today announced the addition of three new Certified Financial Planners® to Money Talk, Schwab's personal finance column designed to help everyday Americans... Keep Reading...

Climate Global and Moody's Power the First Index and ETF of Climate-Resilient REITs

Climate Global and Exchange Traded Concepts announced the Climate Global Climate-Resilient REIT Index ETF (Ticker: CLIM), an exchange-traded fund designed to provide exposure to U.S. equity Real Estate Investment Trusts (REITs) while systematically incorporating insurance-grade climate and... Keep Reading...

T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES DECEMBER 31, 2025 FINANCIAL RESULTS AND DECLARED TOTAL DISTRIBUTIONS OF $0.69 PER SHARE IN Q4 2025

T. Rowe Price OHA Select Private Credit Fund (the "Company" or "OCREDIT") today reported financial results and total distributions of $0.69 per share for the quarter ended December 31, 2025. As private credit remains a key driver of financing solutions within credit markets, OCREDIT closed the... Keep Reading...
AmeriTrust Provides Corporate Update

AmeriTrust Provides Corporate Update

TORONTO, ON / ACCESS Newswire / March 11, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) ("AmeriTrust", "AMT" or the "Company"), a fintech platform targeting automotive finance is pleased to provide an update of corporate activities since the... Keep Reading...

Interactive Chart

Latest Press Releases

Related News